Sharps Technology, Inc. (STSS)
USD 4.75
(-9.35%)
USD 4.75
(-9.35%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 10.12 Million USD | 14.54% |
| 2022 | 8.73 Million USD | 94.3% |
| 2021 | 4.49 Million USD | 92.75% |
| 2020 | 2.33 Million USD | 13.91% |
| 2019 | 2.04 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 1.64 Million USD | -38.58% |
| 2024 Q2 | 1.72 Million USD | 16.53% |
| 2023 Q4 | 2.68 Million USD | 13.81% |
| 2023 FY | 9.23 Million USD | 5.68% |
| 2023 Q2 | 2.53 Million USD | 9.26% |
| 2023 Q3 | 2.35 Million USD | -6.87% |
| 2023 Q1 | 2.31 Million USD | -17.71% |
| 2022 Q4 | 2.81 Million USD | 56.74% |
| 2022 Q3 | 1.79 Million USD | -35.53% |
| 2022 Q2 | 2.78 Million USD | 108.46% |
| 2022 Q1 | 1.33 Million USD | -6.51% |
| 2022 FY | 8.73 Million USD | 94.3% |
| 2021 Q1 | 915.14 Thousand USD | 7.47% |
| 2021 FY | 4.49 Million USD | 92.75% |
| 2021 Q3 | 1.34 Million USD | 65.41% |
| 2021 Q2 | 810.88 Thousand USD | -11.39% |
| 2021 Q4 | 1.43 Million USD | 6.64% |
| 2020 Q4 | 851.53 Thousand USD | 35.81% |
| 2020 Q3 | 627.01 Thousand USD | 0.0% |
| 2020 FY | 2.33 Million USD | 13.91% |
| 2019 FY | 2.04 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 104.27 Million USD | 90.288% |
| AngioDynamics, Inc. | 252.41 Million USD | 95.988% |
| AtriCure, Inc. | 327.05 Million USD | 96.904% |
| Avinger, Inc. | 18.63 Million USD | 45.667% |
| Azenta, Inc. | 336.26 Million USD | 96.989% |
| BioLife Solutions, Inc. | 117.57 Million USD | 91.387% |
| The Cooper Companies, Inc. | 1.82 Billion USD | 99.445% |
| Daxor Corporation | 1.28 Million USD | -690.826% |
| Ekso Bionics Holdings, Inc. | 24.19 Million USD | 58.139% |
| Femasys Inc. | 15.2 Million USD | 33.379% |
| GlucoTrack, Inc. | 7.1 Million USD | -42.549% |
| Harvard Bioscience, Inc. | 58.58 Million USD | 82.713% |
| Hologic, Inc. | 1.34 Billion USD | 99.247% |
| ICU Medical, Inc. | 717.04 Million USD | 98.588% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 99.658% |
| KORU Medical Systems, Inc. | 26.1 Million USD | 61.212% |
| LeMaitre Vascular, Inc. | 90.33 Million USD | 88.79% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 8586.328% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 8586.328% |
| Masimo Corporation | 867 Million USD | 98.832% |
| Microbot Medical Inc. | 9.85 Million USD | -2.756% |
| Meihua International Medical Technologies Co., Ltd. | 18.42 Million USD | 45.024% |
| Merit Medical Systems, Inc. | 459.92 Million USD | 97.798% |
| Nephros, Inc. | 9.78 Million USD | -3.502% |
| NovoCure Limited | 613.92 Million USD | 98.351% |
| NEXGEL, Inc. | 4.09 Million USD | -147.233% |
| NEXGEL, Inc. | 4.09 Million USD | -147.233% |
| Singular Genomics Systems, Inc. | 102.24 Million USD | 90.096% |
| OraSure Technologies, Inc. | 125.34 Million USD | 91.921% |
| Pro-Dex, Inc. | 7.37 Million USD | -37.255% |
| Pulse Biosciences, Inc. | 43.57 Million USD | 76.76% |
| Predictive Oncology Inc. | 15.22 Million USD | 33.506% |
| Precision Optics Corporation, Inc. | 8.52 Million USD | -18.828% |
| QuidelOrtho Corporation | 1.35 Billion USD | 99.253% |
| Repligen Corporation | 261.12 Million USD | 96.122% |
| Sanara MedTech Inc. | 61.12 Million USD | 83.433% |
| STAAR Surgical Company | 224.55 Million USD | 95.49% |
| Utah Medical Products, Inc. | 13.26 Million USD | 23.636% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 99.436% |
| Jin Medical International Ltd. | 3.91 Million USD | -158.493% |